Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain retraining trial aims to ease chronic fatigue and long COVID symptoms

NCT ID NCT06933173

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 10, 2026 · Updated 2 times

Summary

This study is testing a mind-body program called DNRS for people with ME/CFS (chronic fatigue syndrome) who may also have Long COVID. The program uses brain retraining to help calm overactive nerves and improve symptoms like fatigue, pain, and mood. Researchers will track quality of life, daily activity, and sleep in 200 adults over several months to see if the program works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Mar 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older; * Individuals diagnosed with ME/CFS, according to the Institute of Medicine (2015) criteria, for more than six months. Exclusion Criteria: Individuals who: 1) are too ill to participate; 2) lack reliable internet; 3) cannot communicate in English; 4) Presently have or ever had inflammatory bowel disease; and/or 5) Have been prescribed or used an oral or systemic (infusion) antibiotic in the past one month-;; 6) are participating in a concurrent study; 7) are participating in a concurrent mind-body intervention during the study period including * Art Therapy * Autogenic training * Biofeedback/neurofeedback * Breathing exercise * Cognitive restructuring * Dynamic Neural Retraining System * Emotional Freedom Techniques (EFT) * Eye movement desensitization and reprocessing (EMDR) * Guided imagery * Hypnotherapy/self-hypnosis * Meditation (mindfulness, mantra, guided, transcendental) * Mindfulness-based cognitive therapy (MBCT) * Mindfulness-based Stress Reduction (MBSR) * Music therapy * Neurolinguistic programming * Psychological flexibility * Qigong * Relaxation therapy (relaxation response, progressive muscle relaxation) * Tai Chi * Visualization * Yoga and/or starting any other new treatment during the study period, including any mind-body therapy, psychotherapy, prescription medication, over-the-counter medication, etc; 8) have any active medical condition (untreated/uncontrolled) that may explain the presence of fatigue including: * untreated hypothyroidism (including Hashimoto's disease) * hyperthyroidism * diabetes mellitus * iron deficiency anemia * other treatable anemia * iron overload syndrome * adrenal insufficiency * Cushing's syndrome * anorexia nervosa * iatrogenic conditions such as side effects or interactions of medication(s) or supplements • Rheumatological disorders: * rheumatoid arthritis * lupus * polymyositis * polymyalgia rheumatica * Sjogren's Syndrome * Ehlers Danlos Syndromes \[Hypermobility type\] • Other heritable disorders of connective tissue: * Marfan syndrome * Stickler syndrome etc. * Multiple sclerosis * Celiac disease * Note: Patients with celiac disease can present without gastrointestinal symptoms • Immune disorders * such as HIV/AIDS • Sleep disorders * including obstructive sleep apnea • Prior illnesses may relapse or may not have completely resolved during treatment. * Examples are certain malignancies * leukemia * infectious diseases such as tuberculosis and chronic hepatitis • Active primary psychiatric disorders * eating disorders * alcohol * substance use disorder

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myalgic encephalomyelitis/chronic fatigue syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Peter Lougheed Hospital

    RECRUITING

    Calgary, Alberta, Canada

  • University of Alberta Hospital/Kaye Edmonton Clinic

    RECRUITING

    Edmonton, Alberta, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.